BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCL11B, CTIP-2, 64919, ENSG00000127152, CTIP2, hRIT1-alpha, Q9C0K0 AND Prognosis
11 results:

  • 1. Differential expression of bcl11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
    Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
    Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. T-cell lymphoma patient harboring bcl11b mutations had favorable overall survival.
    Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. bcl11b expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
    Abe H; Kamimura K; Okuda S; Watanabe Y; Inoue J; Aoyagi Y; Wakai T; Kominami R; Terai S
    Cancer Med; 2023 Jul; 12(14):15650-15663. PubMed ID: 37293953
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Decreased TCF1 and bcl11b expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
    Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
    Front Immunol; 2022; 13():985280. PubMed ID: 36211334
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance].
    Wang YJ; Zhang HL; Li J; Bu P; Zhang F; Xi YF
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):904-909. PubMed ID: 34344074
    [No Abstract]    [Full Text] [Related]  

  • 6. Haploinsufficiency of bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
    Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
    J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low expression of T-cell transcription factor bcl11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
    Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
    J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
    Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
    J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Ambesi-Impiombato A; De Keersmaecker K; Hadler M; Paietta E; Tallman MS; Rowe JM; Forne C; Rue M; Ferrando AA
    Blood; 2013 Jul; 122(1):74-82. PubMed ID: 23687089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive cytogenetic study of primary cutaneous gamma-delta T-cell lymphoma by means of spectral karyotyping and genome-wide single nucleotide polymorphism array.
    Yamamoto-Sugitani M; Kuroda J; Shimura Y; Nagoshi H; Chinen Y; Ohshiro M; Mizutani S; Kiyota M; Nakayama R; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Cancer Genet; 2012 Sep; 205(9):459-64. PubMed ID: 22819381
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma.
    Oshiro A; Tagawa H; Ohshima K; Karube K; Uike N; Tashiro Y; Utsunomiya A; Masuda M; Takasu N; Nakamura S; Morishima Y; Seto M
    Blood; 2006 Jun; 107(11):4500-7. PubMed ID: 16484591
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.